Senior Project Manager, R&D: Drug Development
CSL
About this role
A Drug Development Project Manager at CSL coordinates scientific strategy and operational delivery across discovery, clinical, regulatory, CMC and commercial functions to advance potential medicines toward patients. The role drives complex, global programmes by aligning multidisciplinary teams, making timely decisions, and ensuring milestones are met. It sits within CSL’s R&D organisation during a period of transformation, offering influence on strategic development programmes.
Skills
Qualifications
About CSL
csl.comCSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
Recent company news
About CSL
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for CSL.
Salary
$138k – $185k
per year
More jobs at CSL
Similar Jobs
Drug Product Project Leader (m/f/d) – Associate Director Science & Technology
Diversity Employment
Sr. Scientist, Analytical R&D
MSD
Director of AI Engineering Pfizer R&D
Pfizer
Associate Director - R&D Information Research IT (Hybrid)
AbbVie
Senior Manager - R & D Information Research IT (Hybrid)
AbbVie
AI Lead: Drug Discovery and Development
AstraZeneca